Inhalation innovation: phase 2 study design of inhaled nintedanib in the treatment of idiopathic pulmonary fibrosis

M. Kreuter, H. M. Lazarus2, D. Murwin, E. Alhaja, C. Conoscenti, J. Lee (2025). Poster presented at European Respiratory Society (ERS) Congress